Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Clinical Data
Special Reports
2021's top 10 clinical trial flops
Thousands of studies are registered each year, so there is always an array of disappointing results to choose from for our annual Top 10 list.
Phil Taylor
Mar 1, 2022 3:00am
Strike 3: Aptinyx's pain prospect flunks third midphase trial
Aug 12, 2022 8:23am
Pfizer's 20-valent pneumococcal vaccine hits goal in infants
Aug 12, 2022 8:00am
Vyne to reevaluate pipeline after eczema fail uproots plans
Aug 10, 2022 11:23am
Elevated liver enzymes force Centessa to drop another asset
Aug 10, 2022 9:34am
Innovent’s rival to AbbVie, J&J psoriasis drugs clears phase 2
Aug 10, 2022 6:50am
More News
AstraZeneca ADC advances as Keytruda data make lung cancer case
Aug 9, 2022 6:59am
Verona’s COPD drug hits goal in phase 3, teeing up FDA filing
Aug 9, 2022 6:40am
3 patients hospitalized in uniQure Huntington's disease trial
Aug 8, 2022 11:45am
Kodiak asset matches Regeneron’s Eylea in macular edema phase 3
Aug 8, 2022 9:53am
See more
